(Q40978262)

25 September 2017

title

The evolution of Radiation Therapy Oncology Group (RTOG) protocols for nonsmall cell lung cancer (English)

1 reference

25 September 2017

The Evolution of Radiation Therapy Oncology Group (RTOG) protocols for nonsmall cell lung cancer (English)

1 reference

https://api.crossref.org/works/10.1016/0360-3016(95)00084-C

27 June 2024

author name string

R. W. Byhardt

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7635796

27 June 2024

language of work or name

English

0 references

publication date

1 July 1995

1 reference

25 September 2017

30 July 1995

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=7635796

full work available at URL

27 June 2024

https://api.elsevier.com/content/article/PII:036030169500084C?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/0360-3016(95)00084-C

https://api.elsevier.com/content/article/PII:036030169500084C?httpAccept=text/plain

27 June 2024

1 reference

https://api.crossref.org/works/10.1016/0360-3016(95)00084-C

International Journal of Radiation Oncology Biology Physics

27 June 2024

published in

1 reference

25 September 2017

volume

32

1 reference

25 September 2017

issue

5

1 reference

25 September 2017

page(s)

1513-1525

1 reference

25 September 2017

cites work

Cancer statistics, 1994.

3

1 reference

https://api.crossref.org/works/10.1016/0360-3016(95)00084-C

Concurrent Radiotherapy and Chemotherapy for Locally Advanced Non-Small-Cell Cancer of the Lung Report of a Clinical Trial and Review of the Literature

27 June 2024

4

1 reference

https://api.crossref.org/works/10.1016/0360-3016(95)00084-C

The influence of field size and other treatment factors on pulmonary toxicity following hyperfractionated irradiation for inoperable non-small cell lung cancer (NSCLC)--analysis of a Radiation Therapy Oncology Group (RTOG) protocol

27 June 2024

5

1 reference

https://api.crossref.org/works/10.1016/0360-3016(95)00084-C

A phase I/II study to evaluate accelerated fractionation via concomitant boost for squamous, adeno, and large cell carcinoma of the lung: report of Radiation Therapy Oncology Group 84-07

27 June 2024

6

1 reference

https://api.crossref.org/works/10.1016/0360-3016(95)00084-C

Large-dose fractionation (hypofractionation).

27 June 2024

9

1 reference

https://api.crossref.org/works/10.1016/0360-3016(95)00084-C

Fractionation: a paradigm for clinical research in radiation oncology.

27 June 2024

10

1 reference

https://api.crossref.org/works/10.1016/0360-3016(95)00084-C

Interruptions of high-dose radiation therapy decrease long-term survival of favorable patients with unresectable non-small cell carcinoma of the lung: analysis of 1244 cases from 3 Radiation Therapy Oncology Group (RTOG) trials

27 June 2024

12

1 reference

https://api.crossref.org/works/10.1016/0360-3016(95)00084-C

Five-year survival after hyperfractionated radiation therapy for non-small-cell carcinoma of the lung (NSCCL): results of RTOG protocol 81-08.

27 June 2024

13

1 reference

https://api.crossref.org/works/10.1016/0360-3016(95)00084-C

A randomized phase I/II trial of hyperfractionated radiation therapy with total doses of 60.0 Gy to 79.2 Gy: possible survival benefit with greater than or equal to 69.6 Gy in favorable patients with Radiation Therapy Oncology Group stage III non-sm

27 June 2024

14

1 reference

https://api.crossref.org/works/10.1016/0360-3016(95)00084-C

N2 (clinical) non-small cell carcinoma of the lung: prospective trials of radiation therapy with total doses 60 GY by the radiation therapy oncology group

27 June 2024

15

1 reference

https://api.crossref.org/works/10.1016/0360-3016(95)00084-C

Randomized dose-searching phase ILE/II trials of fractionation in radiation therapy for cancer.

27 June 2024

17

1 reference

https://api.crossref.org/works/10.1016/0360-3016(95)00084-C

A randomized trial of induction chemotherapy plus high-dose radiation versus radiation alone in stage III non-small-cell lung cancer

27 June 2024

18

1 reference

https://api.crossref.org/works/10.1016/0360-3016(95)00084-C

Phase I/II study of treatment of locally advanced (T3T4) non-oat cell lung cancer with high dose radiotherapy (rapid fractionation): Radiation Therapy Oncology Group Study

27 June 2024

20

1 reference

https://api.crossref.org/works/10.1016/0360-3016(95)00084-C

Carcinoma of the lung: Hyperfractionation or resection and chemotherapy?

27 June 2024

22

1 reference

https://api.crossref.org/works/10.1016/0360-3016(95)00084-C

The Janeway Lecture 1992. Nine decades of radiobiology: is radiation therapy any the better for it?

27 June 2024

27

1 reference

https://api.crossref.org/works/10.1016/0360-3016(95)00084-C

Initial experience with a practical hyperfractionated accelerated radiotherapy regimen

27 June 2024

28

1 reference

https://api.crossref.org/works/10.1016/0360-3016(95)00084-C

Report of phase II trial of concurrent chemoradiotherapy with radical thoracic irradiation (60 Gy), infusional fluorouracil, bolus cisplatin and etoposide for clinical stage IIIB and bulky IIIA non-small cell lung cancer.

27 June 2024

29

1 reference

https://api.crossref.org/works/10.1016/0360-3016(95)00084-C

Levamisole in a phase I trial

27 June 2024

31

1 reference

https://api.crossref.org/works/10.1016/0360-3016(95)00084-C

Dose fractionation and regeneration in radiotherapy for cancer of the oral cavity and oropharynx. Part 2. Normal tissue responses: acute and late effects

27 June 2024

32

1 reference

https://api.crossref.org/works/10.1016/0360-3016(95)00084-C

The effects of preoperative chemotherapy on the resectability of non-small cell lung carcinoma with mediastinal lymph node metastases (N2 M0).

27 June 2024

34

1 reference

https://api.crossref.org/works/10.1016/0360-3016(95)00084-C

Combined Betaseron R (recombinant human interferon beta) and radiation for inoperable non-small cell lung cancer

27 June 2024

35

1 reference

https://api.crossref.org/works/10.1016/0360-3016(95)00084-C

The importance of surgery to non-small cell carcinoma of lung with mediastinal lymph node metastasis

27 June 2024

36

1 reference

https://api.crossref.org/works/10.1016/0360-3016(95)00084-C

Impact of tumor control on survival in carcinoma of the lung treated with irradiation

27 June 2024

37

1 reference

https://api.crossref.org/works/10.1016/0360-3016(95)00084-C

Thoracic irradiation with or without levamisole (NSC #177023) in unresectable non-small cell carcinoma of the lung: a phase III randomized trial of the RTOG

27 June 2024

38

1 reference

https://api.crossref.org/works/10.1016/0360-3016(95)00084-C

Long-term observations of the patterns of failure in patients with unresectable non-oat cell carcinoma of the lung treated with definitive radiotherapy. Report by the Radiation Therapy Oncology Group.

27 June 2024

39

1 reference

https://api.crossref.org/works/10.1016/0360-3016(95)00084-C

A prospective randomized study of various irradiation doses and fractionation schedules in the treatment of inoperable non-oat-cell carcinoma of the lung. Preliminary report by the Radiation Therapy Oncology Group

27 June 2024

40

1 reference

https://api.crossref.org/works/10.1016/0360-3016(95)00084-C

Cell proliferation in EMT6 tumors treated with single doses of x-rays or hydroxyurea. I. Experimental results

27 June 2024

42

1 reference

https://api.crossref.org/works/10.1016/0360-3016(95)00084-C

Continuous, hyperfractionated, accelerated radiotherapy (CHART) in non-small cell carcinoma of the bronchus

27 June 2024

43

1 reference

https://api.crossref.org/works/10.1016/0360-3016(95)00084-C

Phase II Trial of Combination Chemotherapy and Irradiation in Non-Small-Cell Lung Cancer, Radiation Therapy Oncology Group 88–04

27 June 2024

45

1 reference

https://api.crossref.org/works/10.1016/0360-3016(95)00084-C

Radiation Therapy Oncology Group (RTOG) 88-08 and Eastern Cooperative Oncology Group (ECOG) 4588: preliminary results of a phase III trial in regionally advanced, unresectable non-small-cell lung cancer

27 June 2024

46

1 reference

https://api.crossref.org/works/10.1016/0360-3016(95)00084-C

Hyperfractionation in the radiation therapy of unresectable non-oat cell carcinoma of the lung: preliminary report of a RTOG Pilot Study

27 June 2024

48

1 reference

https://api.crossref.org/works/10.1016/0360-3016(95)00084-C

Large fraction irradiation with or without misonidazole in advanced non-oat cell carcinoma of the lung: a phase III randomized trial of the RTOG. Radiation Therapy Oncology Group

27 June 2024

49

1 reference

https://api.crossref.org/works/10.1016/0360-3016(95)00084-C

Large fraction radiotherapy plus misonidazole for treatment of advanced lung cancer: report of a phase I/II trial

27 June 2024

50

1 reference

https://api.crossref.org/works/10.1016/0360-3016(95)00084-C

Changes in early and late radiation responses with altered dose fractionation: implications for dose-survival relationships

27 June 2024

51

1 reference

https://api.crossref.org/works/10.1016/0360-3016(95)00084-C

The kinetics of tumour cell proliferation and radiotherapy

27 June 2024

52

1 reference

https://api.crossref.org/works/10.1016/0360-3016(95)00084-C

The hazard of accelerated tumor clonogen repopulation during radiotherapy

27 June 2024

53

1 reference

https://api.crossref.org/works/10.1016/0360-3016(95)00084-C

Dose fractionation and volume effects in normal tissues and tumors

27 June 2024

54

1 reference

https://api.crossref.org/works/10.1016/0360-3016(95)00084-C

27 June 2024

Identifiers

1 reference

25 September 2017

1 reference